Cargando…
Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation
Background: The optimal treatment of flat epithelial atypia (FEA) found on breast core needle biopsy (CNB) is controversial. We performed a retrospective review of our institutional experience with FEA to determine if excisional biopsy may be deferred. Methods: Surgical records from 2009 to 2012 wer...
Autores principales: | Berry, John S, Trappey, Alfred F, Vreeland, Timothy J, Pattyn, Adam R, Clifton, Guy T, Berry, Elizabeth A, Schneble, Erika J, Kirkpatrick, Aaron D, Saenger, Jeffrey S, Peoples, George E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679374/ https://www.ncbi.nlm.nih.gov/pubmed/26722353 http://dx.doi.org/10.7150/jca.12781 |
Ejemplares similares
-
Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence
por: Greene, Julia, et al.
Publicado: (2014) -
Flat epithelial atypia: biological significance on core biopsy
por: Rajan, S, et al.
Publicado: (2010) -
Diagnostic terminology used to describe atypia on breast core needle biopsy: correlation with excision and upgrade rates
por: Tozbikian, Gary, et al.
Publicado: (2019) -
Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients
por: Berry, John S, et al.
Publicado: (2013) -
Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine
por: Greene, Julia, et al.
Publicado: (2014)